🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to research the association between receiving T...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2012-07
Trial ID
NCT01626248
The primary objectives of the study are to estimate the risk of major conge...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-10-27
Trial ID
NCT05658497
Treatments Being Tested
Phase IV, proof-of-concept, randomized, open-label, multi-center, two-arm, ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-11-01
Trial ID
NCT00771043
Treatments Being Tested
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
Multiple sclerosis (MS) is at onset an immune-mediated demyelinating diseas...
Status
Completed
Location
Northwestern University, Feinberg School of Medicine
Start Date
2005-11-16
Trial ID
NCT00273364
Treatments Being Tested
This was a multicenter, randomized, open-label, parallel-group, active-cont...
Status
Terminated
Location
Research Site
Start Date
2010-03
Trial ID
NCT01058005
Treatments Being Tested
This is a randomized, rater blinded trial in patients who interrupt treatme...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01071083
Treatments Being Tested
The purpose of this study is to determine if natalizumab in combination wit...
Status
Completed
Location
University of Alabama-Birmingham, Department of Neurology
Start Date
2002-01
Trial ID
NCT00030966
Treatments Being Tested